Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MSI-H/dMMR + TMB-L

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related biomarkers:

‹

›

MSI-H/dMMR + TMB-L	Pancreatic Cancer	MSI-H/dMMR + TMB-L	Pancreatic Cancer	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
MSI-H/dMMR + TMB-L	Cholangiocarcinoma	MSI-H/dMMR + TMB-L	Cholangiocarcinoma	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
MSI-H/dMMR + TMB-L	Colorectal Cancer	MSI-H/dMMR + TMB-L	Colorectal Cancer	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
MSI-H/dMMR + TMB-L	Gastric Cancer	MSI-H/dMMR + TMB-L	Gastric Cancer	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
MSI-H/dMMR + TMB-L	Small Intestinal Carcinoma	MSI-H/dMMR + TMB-L	Small Intestinal Carcinoma	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3